http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-101485247-B1
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C233-65 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-166 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P19-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P17-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-166 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C233-65 |
| filingDate | 2013-06-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2015-01-22-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2015-01-22-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | KR-101485247-B1 |
| titleOfInvention | Novel biphenyl-3-carboxamide derivatives or salt thereof and pharmaceutical composition for treating or preventing autoimmune diseases comprising the same |
| abstract | The present invention relates to a novel biphenyl-3-carboxamide derivative or a salt thereof and a pharmaceutical composition for treating or preventing an autoimmune disease, which comprises the biphenyl-3-carboxamide derivative or a salt thereof as an active ingredient. It can be effectively used as a pharmaceutical composition or immunosuppressive agent capable of preventing or treating autoimmune diseases such as rheumatoid arthritis and the like because of its excellent effect of inhibiting the phagocytic action of macrophages. |
| priorityDate | 2012-06-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 171.